Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Authors

Showing 4 results for author "Vishw Patel".

Back to authors

$Thumbnail for Early Real-World Outcomes of Revumenib Versus Venetoclax-Based Salvage Therapy in Relapsed or Refractory Acute Leukemia$

AML - 911

Early Real-World Outcomes of Revumenib Versus Venetoclax-Based Salvage Therapy in Relapsed or Refractory Acute Leukemia

Vishw Patel

Poster Presenter: Vishw Patel

Thumbnail for Real-World Safety Comparison of BTK Inhibitors in Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis of Acalabrutinib, Ibrutinib, and Zanubrutinib

CLL - 1019

Real-World Safety Comparison of BTK Inhibitors in Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis of Acalabrutinib, Ibrutinib, and Zanubrutinib

Vishw Patel

Poster Presenter: Vishw Patel

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Real-World Outcomes of Pirtobrutinib Versus Venetoclax After Covalent BTK Inhibitor Exposure in CLL/SLL

CLL - 916

Real-World Outcomes of Pirtobrutinib Versus Venetoclax After Covalent BTK Inhibitor Exposure in CLL/SLL

Vishw Patel

Poster Presenter: Vishw Patel

Thumbnail for Early IVIG Use and Infectious Complications After Bispecific Antibody Therapy in Multiple Myeloma

MM - 893

Early IVIG Use and Infectious Complications After Bispecific Antibody Therapy in Multiple Myeloma

Vishw Patel

Poster Presenter: Vishw Patel

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors